MedPath

None

Brand Name: None

Generic Name: Bortezomib

Active
Registration Number

DRP-11599

Dosage Form

Lyophilized Powder for Injection (S.C./I.V.)

Issuance Date

March 31, 2022

Expiry Date

March 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.5 mg
PackagingType I Clear Tubular Glass Vial with Gray Bromobutyl Rubber Stopper (Lyo-gloo) and Aluminum Seal (Lacquered) with Red PP Disk (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Proteasome Inhibitor)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

BortezomibActive
Monograph: Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform